# Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

> clinical trial · VERIFIED · 2026-07-06

Status: COMPLETED · Sponsor: Intra-Cellular Therapies, Inc. · Condition: Schizophrenia or Schizoaffective

- Company: Intra-Cellular Therapies, Inc.
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT06627413

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.